Effect of Alternate Day Fasting Over Standard Medical Management Alone to Reverse Non-alcoholic Steatohepatitis.

Who May Qualify: - Age 18-65 years. BMI 25-40kg/m3, and CAP more than 290 - Stable weight in the last 3 months prior to enrolling in the study(\<5kg weight variation) - Imaging showed steatotic liver disease, liver stiffness \<14kPa measured by fibroscan - Histologically proven NASH/MASH, fibrosis up to F3 - Subjects willing to participate in the study Exclusion Criter - Liver stiffness \>14kPa measured by fibroscan or Fibrosis \>F3 - Diabetes with HbA1c\>8.5% - Patients with another co-existing active liver disease e.g. hepatitis B or C, alcoholic liver disease - Patients with cirrhosis, hepatocellular carcinoma(HCC), or other malignancy - Chronic kidney disease, cardiovascular disorders, uncontrolled hypertension - Chronic infections, chronic inflammatory diseases - Patients on weight loss medications e.g semaglutide - Pregnant or lactating women and those planning a pregnancy A patient who is not willing to participate in the study or failed to provide the consent Always talk to your doctor about whether this trial is right for you.